4.8 Review

Extracellular vesicles and particles impact the systemic landscape of cancer

Journal

EMBO JOURNAL
Volume 41, Issue 18, Pages -

Publisher

WILEY
DOI: 10.15252/embj.2021109288

Keywords

biomarkers; cancer; extracellular vesicles and particles; metastasis; therapeutic deliverables

Funding

  1. National Cancer Institute [CA232093, CA163117, CA210240, CA207983, CA218513]
  2. Thompson Family Foundation
  3. Tortolani Foundation
  4. Pediatric Oncology Experimental Therapeutics Investigator's Consortium
  5. Malcolm Hewitt Weiner Foundation
  6. Manning Foundation
  7. Sohn Foundation
  8. Theodore A. Rapp Foundation
  9. Hartwell Foundation
  10. Children's Cancer and Blood Foundation
  11. AHEPA Vth District Cancer Research Foundation
  12. United States Department of Defense [W81XWH-20-1-0263]

Ask authors/readers for more resources

Intercellular cross talk between cancer cells and stromal and immune cells is crucial for tumor progression and metastasis. Extracellular vesicles and particles (EVPs) play a significant role as messengers carrying bioactive molecules between cells in cancer. EVPs influence tumor cell growth, immune cell function, and stromal cell activation, affecting local tumor progression and metastasis.
Intercellular cross talk between cancer cells and stromal and immune cells is essential for tumor progression and metastasis. Extracellular vesicles and particles (EVPs) are a heterogeneous class of secreted messengers that carry bioactive molecules and that have been shown to be crucial for this cell-cell communication. Here, we highlight the multifaceted roles of EVPs in cancer. Functionally, transfer of EVP cargo between cells influences tumor cell growth and invasion, alters immune cell composition and function, and contributes to stromal cell activation. These EVP-mediated changes impact local tumor progression, foster cultivation of pre-metastatic niches at distant organ-specific sites, and mediate systemic effects of cancer. Furthermore, we discuss how exploiting the highly selective enrichment of molecules within EVPs has profound implications for advancing diagnostic and prognostic biomarker development and for improving therapy delivery in cancer patients. Altogether, these investigations into the role of EVPs in cancer have led to discoveries that hold great promise for improving cancer patient care and outcome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available